Project Grant K99AI184677
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $411,078 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. The award supports research to identify novel antifungal compounds derived from symbiotic bacteria—microorganisms that co-exist with and provide benefits to eukaryotic hosts—with the objective of...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a Project Grant totaling $186,758.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for research titled "Infection-Induced Cell Cycle Diversion Promotes Macrophage Inflammatory Biogenesis." The award, effective February 9, 2026, with completion targeted for January 31, 2028, supports investigator-initiated biomedical...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $425,226 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 25, 2025, with a completion date of May 31, 2027. This research project investigates the engineering of trained innate immunity using biomaterial implants to establish feasibility and control systemic immune responses. The primary...
- Federal Grant Award Summary The University of Michigan's Regents received a $411,078 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 7, 2026 through March 31, 2028. This research grant supports investigator-initiated biomedical research aimed at understanding the immunological mechanisms underlying early-life microbial exposure and its impact on immune system...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a Project Grant totaling $132,300 on July 7, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research will be conducted at the University of Michigan's Ann Arbor campus through June 30, 2027. This project supports basic biomedical research investigating the multifaceted roles of phosphatidylinositol...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $3.11 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 23, 2025, for a project period extending through June 30, 2029. This grant supports the development of next-generation concanamycin A (CMA) and concanamycin B (CMB) derivative compounds designed to inhibit HIV Nef protein, a viral factor that...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a Project Grant totaling $411,780 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 3, 2026, with completion scheduled for January 31, 2028. This research project will deliver scientific investigation into the virulence determinants of human-pathogenic atypical Toxoplasma gondii strains, focusing on...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $250,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 21, 2025, with a completion date of July 31, 2026. The award supports the development of a novel synthetic immunological niche (IN) scaffold technology designed to analyze and predict immune response heterogeneity in food allergies. The research...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan $419,274 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 8, 2025, with a completion date of June 30, 2027. This Project Grant funds research to understand the influence of climate and environmental factors on blastomycosis incidence and seasonality in the Northern Great Lakes states. The research compiles and analyzes the...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $598,906 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 10, 2026, with a completion date of March 31, 2031. This research grant supports a multi-year investigation into the mechanisms underlying respiratory viral infections in hospitalized children and their association with asthma development. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a Project Grant totaling $194,400 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. This research initiative examines the role of organelle contact sites in macrophage antifungal responses, specifically investigating how membrane contact sites between cellular organelles regulate immune signaling and antimicrobial functions in response to Candida albicans infection. The research addresses a critical public health need, as invasive fungal infections caused by C. albicans are estimated to result in nearly one million deaths annually, with phagocytic cells serving as crucial defenders against systemic infection. The project builds on preliminary findings demonstrating that the endoplasmic reticulum stress sensor IRE1α coordinates membrane contact sites to promote phagosomal calcium flux and fungal killing in macrophages. Through this two-year funding award, the University of Michigan's research team will advance understanding of how membrane contact site regulation controls macrophage antifungal immunity, with the ultimate objective of identifying regulatory mechanisms that could support development of host-targeted therapeutic strategies for fungal disease treatment. The research will be conducted at the University of Michigan's Ann Arbor campus.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $194.4k | 3/31/26 |